BioSpace News Archive

Drug Development

ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation

Single Phase 3 trial may be sufficient for approval of atrial fibrillation indication

August 3, 2018
·
6 min read
Business

Vital Therapies Announces Upcoming 2018 Second Quarter Financial Results Conference Call With Webcast

Vital Therapies, Inc. will release its second quarter 2018 financial results after the market closes on Tuesday, August 7, 2018 followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast.

August 3, 2018
·
1 min read
Business

Aqualitas Announces Addition of Kyle Atkinson as Director of Medical Sales and Client Care

Aqualitas Inc. announced that Kyle Atkinson has joined its management team as Director of Medical Sales and Client Care.

August 3, 2018
·
3 min read
Business

NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash GuidanceManagement to Host Conference Call Today at 4:30 p.m. ET

NewLink Genetics Corporation announced its clinical plan and strategy, reported consolidated financial results for the second quarter of 2018, and revised its cash guidance.

August 3, 2018
·
13 min read
Drug Development

OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial

OmniSeq, Inc.® announced it is participating as a CLIA-certified/accredited laboratory for the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial

August 3, 2018
·
4 min read
Business

Apellis Pharmaceuticals Reports Second Quarter 2018 Business Update and Financial Results

Commenced Phase 3 Trial of APL-2 in Paroxysmal Nocturnal Hemoglobinuria (PNH); APL-2 in Geographic Atrophy (GA) Remains On Track to Advance into Phase 3 in 2H18

August 3, 2018
·
9 min read
Business

PharmaVOICE Magazine Announces the 2018 PharmaVOICE 100 and Red Jacket Award Honorees

For more than a dozen years, PharmaVOICE magazine has recognized the most inspirational, motivational, and transformative individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue.

August 3, 2018
·
3 min read
Business

Andrea Hartong, CNOR, CLNC is Elected to the American Health Council’s Nurse Board

The American Health Council proudly announces the election of Andrea Hartong, CNOR, CLNC to their Nursing Board for her examples of healthcare excellence.

August 3, 2018
·
3 min read
Business

Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.

Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange transaction with TYG Solutions Corp. (OTC: TYYG).

August 3, 2018
·
3 min read
Business

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Thursday, August 9, 2018

Interpace Diagnostics Group, Inc. announced that it will report its second quarter 2018 financial results after the close of market on Thursday, August 9, 2018 at 4:30 p.m. ET.

August 3, 2018
·
4 min read